Glerelin 22.5mg Injection

About

Goserelin is a synthetic analogue of gonadotropin-releasing hormone (GnRH) designed to potently inhibit pituitary gonadotropin secretion. Upon initial administration, it triggers a transient surge in luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which can lead to a temporary increase in sex hormone levels, known as a 'flare' effect. However, with continuous and sustained administration, goserelin induces desensitization and downregulation of GnRH receptors in the pituitary gland. This crucial process results in a profound and sustained suppression of LH and FSH release. Consequently, circulating levels of testosterone in men and estradiol in women are significantly reduced, making goserelin highly effective in the management of various hormone-sensitive cancers, such as prostate and breast cancer, as well as other gynecological conditions like endometriosis and uterine fibroids, by creating a medical castration state.

Uses

• Treatment of prostate cancer.
• Management of breast cancer in pre/perimenopausal women.
• Endometriosis management.
• Uterine fibroids treatment.

Directions For Use

This injection is administered subcutaneously into the anterior abdominal wall by a healthcare professional, typically every 28 days or as prescribed.

Benefits

• Reduces sex hormone levels effectively.
• Provides palliative care for advanced prostate cancer.
• Helps manage hormone-sensitive breast cancer.
• Alleviates symptoms of endometriosis.
• Can shrink uterine fibroids.
• Administered as a convenient long-acting injection.

Side Effects

• Hot flashes
• Sweating
• Decreased libido
• Erectile dysfunction (men)
• Vaginal dryness (women)
• Headache
• Mood changes
• Bone pain (initial flare)
• Injection site reactions
• Weight gain
• Bone density loss (long-term)
• Fatigue

Safety Measures

• Alcohol - Moderate alcohol consumption is generally not contraindicated, but excessive intake may exacerbate hot flashes or mood changes in some individuals.
• Pregnancy - Goserelin is contraindicated in pregnancy due to its hormonal effects and potential for fetal harm. Effective non-hormonal contraception is required.
• Breastfeeding - Breastfeeding is not recommended during Goserelin treatment as it may interfere with lactation and potentially harm the infant.
• Liver - Use with caution in patients with hepatic impairment. No specific dose adjustment is usually required, but monitor for adverse effects.
• Kidney - Use with caution in patients with severe renal impairment. No specific dose adjustment is usually required, but monitor for adverse effects.
• Lung - No specific lung-related safety concerns are commonly associated with Goserelin.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.